Kwarlay.com

Navigating the News Maze with Clarity

Medicine

AD04 Advancing to Phase III Amid Promising Results in Alcohol Use Disorder

Cary Claiborne, CEO, Adial Pharmaceuticals, discusses AD04’s development timeline and next steps towards approval for alcohol use disorder.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *